301 related articles for article (PubMed ID: 31497529)
1. Acrodermatitis continua of Hallopeau: clinical perspectives.
Smith MP; Ly K; Thibodeaux Q; Bhutani T; Liao W; Beck KM
Psoriasis (Auckl); 2019; 9():65-72. PubMed ID: 31497529
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau.
Husson B; Barbe C; Hegazy S; Seneschal J; Aubin F; Mahé E; Jullien D; Sbidian E; D'Incan M; Conrad C; Brenaut E; Girard C; Richard MA; Bachelez H; Viguier M;
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2330-2338. PubMed ID: 32030802
[TBL] [Abstract][Full Text] [Related]
3. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
[TBL] [Abstract][Full Text] [Related]
4. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
5. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
6. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
[TBL] [Abstract][Full Text] [Related]
7. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
[TBL] [Abstract][Full Text] [Related]
8. Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.
Shi L; Zeng L; Huang X; Wang B; Zhang Y; Zhang G
Clin Cosmet Investig Dermatol; 2023; 16():951-957. PubMed ID: 37051587
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.
Smirnova LM; Vertieva EY; Olisova OY; Anpilogova EM
Biologics; 2019; 13():83-87. PubMed ID: 31190732
[No Abstract] [Full Text] [Related]
10. Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities?
Chularojanamontri L; Rattanakorn K; Julanon N; Chuamanochan M; Griffiths CEM
Exp Dermatol; 2023 Aug; 32(8):1235-1245. PubMed ID: 37057764
[TBL] [Abstract][Full Text] [Related]
11. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
[TBL] [Abstract][Full Text] [Related]
12. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
[TBL] [Abstract][Full Text] [Related]
13. Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report.
Alorainy M; Alshaya M; Al-Rikabi A; Ayesh M; Alsaif F
Case Rep Dermatol; 2017; 9(3):259-264. PubMed ID: 29422844
[TBL] [Abstract][Full Text] [Related]
14. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
Cirone KD; Lovegrove FE
SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
[TBL] [Abstract][Full Text] [Related]
15. Pustular Psoriasis: From Pathophysiology to Treatment.
Genovese G; Moltrasio C; Cassano N; Maronese CA; Vena GA; Marzano AV
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944562
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
Miller AC; Holland TE; Cohen DJ
J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
Puig L; Barco D; Vilarrasa E; Alomar A
Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
[TBL] [Abstract][Full Text] [Related]
18. Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.
Samotij D; Gawron E; Szczęch J; Ostańska E; Reich A
Biologics; 2021; 15():107-113. PubMed ID: 33948082
[TBL] [Abstract][Full Text] [Related]
19. Acute Generalized Pustular Psoriasis Developed Resistance to Adalimumab Was Successfully Treated with Narrowband Ultraviolet B and Acitretin: A Case Report.
Yang X; Wang J; Wang H; Kong M; Chen Q
Clin Cosmet Investig Dermatol; 2022; 15():2541-2546. PubMed ID: 36466946
[TBL] [Abstract][Full Text] [Related]
20. Acrodermatitis continua of hallopeau successfully treated with adalimumab.
Sopkovich JA; Anetakis Poulos G; Wong HK
J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
